Search
Now showing items 11-20 of 58
-
Global surveillance for COVID-19 disease caused by human infection with the 2019 novel coronavirus, Interim guidance, 27 February 2020
Background: This document summarizes WHO’s revised guidance for global surveillance of COVID-19 disease caused by infection with the 2019 novel coronavirus. WHO will continue to update this guidance as new information about ... -
Home care for patients with COVID-19 presenting with mild symptoms and management of their, Interim guidance, 17 February 2020
Background. WHO has developed this interim guidance to meet the need for recommendations on safe home care for patients with suspected COVID-19 who present with mild symptoms a and on public health measures related to the ... -
Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected, Interim guidance, 13 March 2020
This document is intended for clinicians taking care of hospitalised adult and paediatric patients with severe acute respiratory infection (SARI) when a nCoV infection is suspected. It is not meant to replace clinical ... -
Laboratory biosafety guidance related to coronavirus disease 2019 (COVID-19) Interim guidance 12 February 2020
The purpose of this document is to provide interim guidance on laboratory biosafety related to the testing of clinical specimens of patients that meet the case definition of the novel pathogen identified in Wuhan, China, ... -
Laboratory testing for 2019 novel coronavirus (2019-nCoV) in suspected human cases, Interim guidance, 2 March 2020
Overview. The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a ... -
Infection prevention and control during health care when novel coronavirus (nCoV) infection is suspected, Interim guidance, 25 January 2020
Introduction: This is the first edition of guidance on infection preventionand control (IPC) strategies for use when infection with a novel coronavirus (2019-nCoV) is suspected. It has been adapted from WHO’s Infection ... -
Health workers exposure risk assessment and management in the context of COVID-19 virus, Interim guidance, 4 March 2020
Coronavirus disease (COVID-19) was first detected in Wuhan city, China in December 2019. On 30 January 2020, the WHO Director General declared that the current outbreak constituted a Public Health Emergency of International ... -
COVID-1. Informal consultation on the potential role of chloroquine in the clinical management of COVID 19 infection, draft 13 March 2020
(2020-03-13)Currently, there are no therapeutic agents licensed and available for the treatment of COVID 19. On the 27th of January, WHO convened a meeting of experts to examine the available evidence and prioritize promising therapeutic ... -
Infection Prevention and Control guidance for Long-Term Care Facilities in the context of COVID-19, Interim guidance 21 March 2020
(2020-03-21)Background: On 30 January 2020, WHO announced that the COVID-19 outbreak was a Public Health Emergency of International Concern. Initially, most cases were reported from China and among individuals with travel history to ...